Johnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire Intra-Cellular Therapies, a company whose main asset has the potential to ...

The JP Morgan Healthcare Conference, which is being held in San Francisco this year, has been much more active than last year. Among some of the top news at the conference were M&A deal announcements ...

Paying US federal and state taxes online can be confusing, and one wrong move can result in penalties or extra money owed. We ...

Study from neutral host providers discovers how Wi-Fi and cellular connectivity have overtaken traditional priorities like price and amenities as top considerations for businesses choosing commercial ...

Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

The latest partnership with U.S. Bank is part of Wisetack's innovative embedded origination program, which has reshaped the bank-fintech relationship model by enabling banks to serve both borrowers ...

U.S. Auto Sales, which had multiple used car dealerships in Georgia, has been ordered by a federal judge to pay more than $42 million.

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...

Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

The National Payments Corporation of India (NPCI), the payments body overseeing the popular instant payments rail called UPI, said Tuesday that WhatsApp can now roll out WhatsApp Pay to all its ...